2011
DOI: 10.1016/j.anaerobe.2011.05.007
|View full text |Cite
|
Sign up to set email alerts
|

Screening for lactobacilli with probiotic properties in the infant gut microbiota

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

11
49
0
1

Year Published

2012
2012
2024
2024

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 67 publications
(61 citation statements)
references
References 21 publications
11
49
0
1
Order By: Relevance
“…In the present study, among fifty two strains only six showed interesting viability at pH1.5 after 2 h of exposure. Previous reports indicated that pH (1.5-2) is the lethal acidity value for LAB isolated from human GI tract (Lankaputhra and Shah, 1995;Khalil et al, 2007;Xiaodong et al, 2009;Kirtzalidou et al, 2011). In the stomach, in addition to low pH, the probiotics are, also, subjected to the stress of proteolytic enzyme, pepsin (Holzapfel et al, 1998).…”
Section: Discussionmentioning
confidence: 99%
“…In the present study, among fifty two strains only six showed interesting viability at pH1.5 after 2 h of exposure. Previous reports indicated that pH (1.5-2) is the lethal acidity value for LAB isolated from human GI tract (Lankaputhra and Shah, 1995;Khalil et al, 2007;Xiaodong et al, 2009;Kirtzalidou et al, 2011). In the stomach, in addition to low pH, the probiotics are, also, subjected to the stress of proteolytic enzyme, pepsin (Holzapfel et al, 1998).…”
Section: Discussionmentioning
confidence: 99%
“…Adherence and colonization of Lactobacillus strains in the gastrointestinal tract is the prerequisite for the strains to exhibit beneficial effect on humans (von Ossowski et al, 2010). The assessment of autoaggregation, coaggregation, hydrophobicity, and adherence to intestinal epithelial cell lines (Caco-2 and HT-29 cells) of Lactobacillus strains has been used as an in vitro method to screen strains having probiotic potential (Kos et al, 2003;Vlkov谩 et al, 2008;Tamang et al, 2009;Kirtzalidou et al, 2011).…”
Section: Introductionmentioning
confidence: 99%
“…Not all strains of lactobacilli and bifidobacteria can be used as components of probiotics and probiotic foods, but only those that are of human origin, non-pathogenic, resistant to gastric acid, bile and to the antibiotics, administered in medical practice; they should also have the potential to adhere to the gut epithelial tissue and produce antimicrobial substances; they should allow the conduction of technological processes, in which high concentrations of viable cells are obtained as well as to allow industrial cultivation, encapsulation and freezedrying and they should remain active during storage [11,12]. This requires the mandatory selection of strains of the genera Lactobacillus and Bifidobacterium with probiotic properties.…”
Section: Introductionmentioning
confidence: 99%